Chagas disease and SARS-CoV-2 coinfection does not lead to worse in-hospital outcomes

• Main Author: Molina, Israel
• Publication Date: 2021
• Other Authors: Rodrigues, Fernanda D'Athayde, Moreira, Leila Beltrami, Ferreira, Maria Angelica Pires, Polanczyk, Carisi Anne, Nunes, Maria do Carmo Pereira
• Format: Article
• Language: eng
• Source: Repositório Institucional da UFRGS
• Download full: http://hdl.handle.net/10183/245575
• topic: Doença de Chagas; SARS-CoV-2; Hospitalização

Chagas disease (CD) continues to be a major public health burden in Latina America. Information on the interplay between COVID-19 and CD is lacking. Our aim was to assess clinical characteristics and in-hospital outcomes of patients with CD and COVID-19, and to compare it to non-CD patients. Consecutive patients with confrmed COVID-19 were included from March to September 2020. Genetic matching for sex, age, hypertension, diabetes mellitus and hospital was performed in a 4:1 ratio. Of the 7018 patients who had confrmed COVID-19, 31 patients with CD and 124 matched controls were included (median age 72 (64–80) years-old, 44.5% were male). At baseline, heart failure (25.8% vs. 9.7%) and atrial fbrillation (29.0% vs. 5.6%) were more frequent in CD patients than in the controls (p< 0.05). C-reactive protein levels were lower in CD patients compared with the controls (55.5 [35.7, 85.0] vs. 94.3 [50.7, 167.5] mg/dL). In-hospital management, outcomes and complications were similar between the groups. In this large Brazilian COVID-19 Registry, CD patients had a higher prevalence of atrial fbrillation and chronic heart failure compared with non-CD controls, with no diferences in-hospital outcomes. The lower C-reactive protein levels in CD patients require further investigation.